<DOC>
	<DOCNO>NCT02060019</DOCNO>
	<brief_summary>This study designate evaluate pharmacokinetic interaction amlodipine besylate , valsartan rosuvastatin healthy male volunteer .</brief_summary>
	<brief_title>Pharmacokinetic Interactions Safety Between Exforge Tab . Crestor Tab . Healthy Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Amlodipine , Valsartan Drug Combination</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>1 . Male volunteer age 20 55 year old 2 . The weight range exceed ±20 % ideal weight Ideal weight = [ height 100 ] *0.9 3 . Subjects history significant chronic disease 4 . Judged good health basis electrocardiography ( ECG ) routine laboratory data obtain within 3 week prior study drug administration 5 . Willing adhere protocol requirement sign inform consent form 1 . History clinically significant allergy include drug allergy 2 . History clinically significant hepatic , renal , gastrointestinal , pulmonary , , musculoskeletal , endocrine , psychiatric , hematologic , oncologic , neurologic cardiovascular disease 3 . History genetic muscular disease family history 4. hypotension ( Systolic Blood Pressure ( SBP ) ≤ 105 Diastolic Blood Pressure ( DBP ) ≤ 65 ) hypertension ( SBP ≥ 150 DBP ≥ 100 ) 5 . AST ( Aspartate Transaminase ) , ALT ( ALanine Transaminase ) , total bilirubin ( &gt; 1.5 time normal range 6 . Creatinine clearance &lt; 80mL/min 7 . Subjects history gastrointestinal disease might significantly change ADME ( Absorption , Distribution , Metabolism Excretion ) medicine 8 . Serious injury , surgery acute illness within 4 week prior drug administration 9 . History alcohol , smoke abuse alcohol &gt; 21 units/week , 1 unit=10g=12.5mL pure alcohol smoking &gt; 10 cigarettes/day 10 . Use medication , include herbal product , within 2 week dose 11 . Participated previous clinical trial within 3 month prior drug administration 12 . Subjects whole blood donation within 2 month , component blood donation within month prior drug administration 13 . Special diet know interfere absorption , distribution , metabolism excretion drug ( especially , consumption grapefruit juice ) within 7 day prior drug administration 14 . Clinical laboratory test value positive ( HBsAg , HCV Ab , HIV Ag/Ab , VDRL ) 15 . Subjects consider unsuitable base medical judgement investigator</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Pharmacodynamics</keyword>
	<keyword>Safety</keyword>
	<keyword>Tolerability</keyword>
</DOC>